FLUid management and InDividualized resuscitation in Sepsis (FLUIDS)-A Study protocol for a single-centre,
Sanne Ter Horst1,2, Ewoud Ter Avest1, Jildou van Everdink2
1Department of Acute Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Plos One
|December 19, 2025
Summary
This study will personalize sepsis resuscitation using stroke volume index (SVI) to guide fluids and vasopressors. SVI-guided therapy is expected to reduce fluid volume and improve patient outcomes in the emergency department.
Area of Science:
- Critical Care Medicine
- Cardiovascular Physiology
- Emergency Medicine
Background:
- Sepsis causes complex hemodynamic disturbances like vasodilation and hypovolemia, necessitating prompt resuscitation.
- Current fluid administration in the emergency department (ED) lacks personalization, impacting patient tolerance and responsiveness.
- Personalized resuscitation strategies are crucial for managing sepsis effectively.
Purpose of the Study:
- To evaluate a personalized hemodynamic resuscitation strategy for sepsis in the ED.
- To utilize continuous non-invasive stroke volume index (SVI) measurements to guide intravenous (IV) fluid therapy and vasopressor initiation.
- To compare SVI-guided resuscitation with standard care in the initial management of sepsis.
Main Methods:
- A single-center, open-label, randomized clinical trial involving 188 adults with suspected sepsis.
- Patients randomized to either an SVI-guided intervention group or a standard care control group.
- Primary endpoint: IV fluid volume administered within the first three hours; secondary endpoints include organ failure, mortality, and fluid-related adverse events.
Main Results:
- Anticipated reduction in IV fluid volume with SVI-guided resuscitation compared to standard care.
- Personalized approach aims to tailor fluid and vasopressor administration to individual hemodynamic needs.
- Potential for improved patient outcomes in sepsis management.
Conclusions:
- SVI-guided resuscitation offers a personalized approach to sepsis management in the ED.
- This strategy may optimize fluid and vasopressor administration, potentially reducing complications.
- Further research is needed to confirm the benefits of personalized hemodynamic resuscitation in sepsis.
Related Concept Videos
Acute Respiratory Failure-V
421
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
421
Acute Kidney Injury IV: Diagnostic Studies and Prevention
243
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
243
Heart Failure VI: Adjunct Therapies
235
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
235


